We’re not surprised that this historical theory of cancer treatment is now rightly being proved for the innovation it is. It was John Beard (1857-1924), an embryologist, who first proposed in 1905 the fact that pancreatic proteolytic enzymes are not merely used for digestion, but also have enormous potential as a cancer treatment. But like many truthtellers, his theories were dismissed by the conventional medical establishment.
However, a handful of savvy practitioners understood the concept and have kept it alive through the years. One such practitioner is Dr. Linda Isaacs. We took notice as a new article written by Isaacs and recently published in Integrative Cancer Therapies reviews the history of the clinical use of pancreatic proteolytic enzymes in cancer treatment and its potential to revolutionize how we treat cancer. It’s a fascinating study in which Beard’s theory is brought to life in a new way.
>> Read Isaacs’ article HERE: https://journals.sagepub.com/doi/full/10.1177/15347354221096077
Linda L. Isaacs, M.D., worked with the late Nicholas J. Gonzalez, M.D., for more than 20 years, using nutritional protocols to treat patients diagnosed with cancer and other serious degenerative illnesses. She has written papers published in the journals Nutrition and Cancer and Alternative Therapies in Health and Medicine, and co-authored the book, The Trophoblast and the Origins of Cancer. Since Dr. Gonzalez’ untimely death in July 2015, she has dedicated herself to continuing the work they both shared.
Learn more about Dr. Isaacs’ work at her website and also in this video interview: